Purified phage endolysins have been used as therapeutics (so-called enzybiotics) against Streptococci in mice [13, 14] and have been proven effective against other Gram-positive pathogens including Enterococcus faecalis and E. faecium [15], Clostridium perfringens [16], group B Streptococci [17], Bacillus anthracis [18] and S. aureus [[19–21]]. Previously, we reported the isolation of the S. aureus bacteriophage vB_SauS-phiIPLA88

(in short, phiIPLA88) belonging to the Siphoviridae family [22]. The complete genome sequence was determined (Accession number NC_011614) and zymogram analysis revealed the presence of a phiIPLA88 virion-associated muralytic enzyme [23]. In this study, we describe the structural component of phiIPLA88 particle, HydH5, which exhibits lytic activity against S. aureus cells. HydH5 contains a CHAP [24, 25] and a LYZ2 [7] domain and the contribution of each to cell lysis GDC-0068 molecular weight has been analysed. Finally, we have determined the optimal activity conditions and heat-labile stability in order to assess

HydH5′s potential as an anti-Staphylococcus agent. Results S. aureus bacteriophage phiIPLA88 contains a structural Olaparib concentration component with a putative cell wall- degrading activity The virions of phage phiIPLA88 possess a structural component with lytic activity as was previously shown by zymogram analysis [23]. This lytic activity corresponded in size to that expected for the protein product of orf58 (72.5 kDa), which is located in the morphogenetic module with most of the phage head and MRIP tail structural genes. Computer-based similarity

searches revealed that protein gp58, designated here as HydH5 (634 amino acids, Acc. Number ACJ64586), showed 91% similarity with putative PG hydrolases identified in S. aureus phi11, phiNM and phiMR25 phages (Acc. Number NP_803302.1, YP_874009.1, YP_001949862.1). A 60% similarity was detected between HydH5 and the recently characterized PG hydrolase gp61 of S. aureus phiMR11 phage [7]. A phylogeny tree was generated from alignment of the known staphylococcal PG hydrolases (Figure 1). The 25 different proteins were clustered into two major groups. No relation between these groups and the previous S. aureus phages classification based on their genome organization was observed [26]. Interestingly, PG hydrolases from phages infecting S. epidermidis strains (phage CNPH82 and phage PH15) were found to be very similar to those from S. aureus phages. Furthermore, conserved-domain analyses of HydH5 identified two typical catalytic domains found in cell wall hydrolases. At its N-terminal region (15 to 149 amino acids) a CHAP (cysteine, histidine-dependent amidohydrolase/peptidase) domain was detected [24, 25]. The C-terminal region (483 to 629 amino acids) showed a LYZ2 (lysozyme subfamily 2 or glucosaminidase) [7] conserved domain.

Department of Physical Education, Sports Science and Recreation Management: Loughborough University; 1997. [PhD thesis] 17. Burke ER, Ekblom B: Influence of fluid ingestion and dehydration on precision and endurance

in tennis. Athletic Trainer 1982, 17:275–277. 18. Ferrauti A, Weber K: Metabolic and ergogenic effects of carbohydrate and caffeine beverages in tennis. J Sports Med Phys Fitness 1997, 37:258–266.PubMed 19. ITF: Official Rules of Tennis. Chicago IL: Triumph Books; 2002. 20. Coyle EF, Montain SJ: Benefits of fluid replacement with carbohydrate during exercise. Med Sci Sports Exer 1992, 24:S324-S330. 21. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, Paffenbarger RS Jr: Compendium of physical activities: classification BGB324 selleck chemical of energy costs of human physical activities. Med Sci Sports Exer 1993, 25:71–80.CrossRef 22. Smekal G, Von Duvillard SP, Rihacek C, Pokan R, Hofmann P, Baron R, Tschan H, Bachl N: A physiological profile of tennis match play. Med Sci Sports Exerc 2001, 33:999–1005.PubMedCrossRef 23. Mendez-Villanueva A, Fernandez-Fernandez J, Bishop D, Fernandez-Garcia B, Terrados N: Activity patterns, blood lactate concentrations and ratings of perceived exertion during a professional singles tennis tournament. Br J Sports Med 2007, 41:296–300.PubMedCrossRef

24. Freckman G, Baumstark A, Jendrike N, Zschornack E, Kocher S, Tshiananga J, Heister F, Haug C: System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther 2010, 12:221–231.CrossRef 25. Vergauwen L, Brouns F, Hespel P: Carbohydrate supplementation improves stroke performance in tennis. Med Sci Sports Exerc 1998, 30:1289–1295.PubMedCrossRef 26. Coyle EF, Hagberg JM, Hurley BF, Martin WH, Ehsani AA, Holloszy JO: Carbohydrate feeding during prolonged strenuous exercise can delay fatigue. J Appl

Fenbendazole Physiol 1983, 55:230–235.PubMed 27. Kovacs MS: Carbohydrate intake and tennis: are there benefits? Br J Sports Med 2006, 40:e13.PubMedCrossRef 28. Jãrhult J, Falck B, Ingemansson S, Nobin A: The functional importance of sympathetic nerves to the liver and endocrine pancreas. Ann Surg 1979, 189:96–100.PubMedCrossRef 29. Yamaguchi N: Sympathoadrenal system in neuroendocrine control of glucose: mechanisms involved in the liver, pancreas, and adrenal gland under hemorrhagic and hypoglycemic stress. Can J Physiol Pharmacol 1992, 70:167–206.PubMedCrossRef 30. Bergeron MF, Maresh CM, Kraemer WJ, Abraham A, Conroy B, Gabaree C: Tennis: a physiological profile during match play. Int J Sports Med 1991, 12:474–479.PubMedCrossRef 31. Currell K, Conway S, Jeukendrup AE: Carbohydrate ingestion improves performance of a new reliable test of soccer performance. Int J Sport Nutr Exerc Metab 2009, 19:34–46.PubMed 32. Winnick JJ, Davis JM, Welsh RS, Carmichael MD, Murphy EA, Blackmon JA: Carbohydrate feedings during team sport exercise preserve physical and CNS function.

CrossRef 12. Sun Y, Li Xq, Cao J, Zhang Wx, Wang HP: Characterization of zero-valent iron nanoparticles. Adv Colloid Interface FK506 molecular weight Sci 2006,120(1–3):47–56.CrossRef 13. Horak D, Petrovsky E, Kapicka A, Frederichs T: Synthesis and characterization of magnetic poly(glycidyl methacrylate) microspheres. J Magn Magn Mater 2007,311(2):500–506.CrossRef 14. Masheva V, Grigorova M, Nihtianova D, Schmidt JE, Mikhov M: Magnetization processes of small gamma-Fe2O3 particles in non-magnetic matrix. J Phys D: Appl Phys 1999,32(14):1595–1599.CrossRef

15. Phenrat T, Saleh N, Sirk K, Tilton RD, Lowry GV: Aggregation and sedimentation of aqueous nanoscale zerovalent iron dispersions. Environ Sci Technol 2007, 41:284–290.CrossRef 16. Wang J, Wei LM, Liu P, Wei H, Zhang YF: Synthesis of Ni nanowires via a hydrazine reduction route in aqueous ethanol solutions assisted by external magnetic fields. NanoMicro Lett 2010, 1:49–52. 17. Einstein A: On the movement of small particles suspended in stationary liquids required by the molecular-kinetic theory of heat. Annalen der Physik 1905, 17:549–560.CrossRef www.selleckchem.com/products/abt-199.html 18. Votruba

V, Muzikar C: Teorie Elektromagnetickeho Pole. Praha: Akademia Karolinum; 1958. 19. Rosicka D, Sembera J: Assessment of influence of magnetic forces on aggregation of zero-valent iron nanoparticles. Nanoscale Res Lett 2010, 6:10. 20. Sembera J, Rosicka D: Computational methods for assessment of magnetic forces between iron nanoparticles and their influence on aggregation. Adv Sci Eng Med 2011,3(1,2):149–154. 21. Rosicka D, Sembera J: Influence of structure of iron nanoparticles in aggregates on their magnetic properties. Nanoscale Res Lett Astemizole 2011, 6:527.CrossRef 22. Stumm W, Morgan JJ: Aquatic Chemistry: Chemical

Equilibria and Rates in Natural Waters. New York: Wiley; 1996. 23. Dzombak DA, Morel FMM: Surface Complexation Modeling: Hydrous Ferric Oxide. 1st edition. New York: Wiley-Interscience; 1990. 24. Lyklema J: Fundamentals of Interface and Colloid Science. Amsterdam: Academic Press; 2005. 25. Sedlak B, Stoll I, Man O: Elektrina a magnetismus. Praha: Academia Karolinum; 1993. Competing interests The authors declare that they have no competing interests. Authors’ contributions DR carried out the study of the assessment of the aggregate structure according to interaction energies of the aggregate and with the inclusion of magnetic and electrostatic forces into the aggregation model. JŠ contributed to the conception of the study and to the interpretation of data, and revised the manuscript. Both authors read and approved the final manuscript.”
“Background Graphene (GR) has become one of the most well-known carbon nanomaterials due to its unique optical, electrical, and thermal properties which arise from its unique 2D hexagonal honeycomb crystal structure.

Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K, Alatossava T: Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 2000, 66:297–303.PubMedCrossRef 40. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP: Detection of Lactobacillus, Pediococcus,

Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001, 67:2578–2585.PubMedCrossRef 41. Bassam Erlotinib BJ, Caetano-Anollés G, Gresshoff PM: Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 1991, 196:80–83.PubMedCrossRef 42. Heilig HGHJ, Zoetendal EG, Vaughan EE, Marteau P, Akkermans AD, de Vos WM: Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific

amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002, 68:114–123.PubMedCrossRef 43. Kok RG, de Waal A, Schut F, Welling GW, BAY 57-1293 order Weenk G, Hellingwerf KJ: Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl Environ Microbiol 1996, 62:3668–3672.PubMed 44. Tilsala-Timisjärvi A, Alatossava T: Development of oligonucleotide primers from the 16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR. Int J Food Microbiol 1997, 35:49–56.PubMedCrossRef 45. Zariffard MR, Saifuddin M, Sha BE, Spear Ribonucleotide reductase GT: Detection of bacterial vaginosis-related organisms by real-time PCR for Lactobacilli, Gardnerella vaginalis and Mycoplasma hominis . FEMS Immunol Med Microbiol 2002, 34:277–281.PubMedCrossRef 46. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R: Use of 16S rRNA gene-targeted group-specific primers for

real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004, 70:7220–7228.PubMedCrossRef 47. Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H, Tanaka R: Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002, 68:5445–5451.PubMedCrossRef 48. Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004, 97:1166–1177.PubMedCrossRef 49. Vignali DA: Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000, 243:243–255.PubMedCrossRef Competing interests VSL Pharmaceuticals, Inc. is financing the article-processing charge. The authors declare that they have no other competing interests. Authors’ contributions BV performed the study design, analysis and interpretation of the data and the writing of the paper.

Lanes: 1 and Fulvestrant chemical structure 6, molecular mass marker; 2 and 7, cell wall protein from 1457ΔlytSR strain; 3 and 8, cell wall protein from wild type strain; 4 and 9, extracellular protein from 1457ΔlytSR strain; 5 and 10, extracellular protein from wild type strain. The results are representative of three independent experiments. Quantitative murein hydrolase assay was further carried out by adding 100 μg of extracellular protein extract to a suspension of heat-killed M. luteus or S. epidermidis

in Tris-HCl buffer, and monitoring the reduction in the suspension turbidity (OD600). However, cell wall hydrolysis performed with extracellular murein hydrolases from 1457ΔlytSRwas undergoing more slowly than that from the parent strain. After 4 hours’ incubation, a decrease of 69% or 44% in turbidity (OD600) was observed in the suspension of M. luteus (Figure 6A) or S. epidermidis (Figure 6B) added with extracellular murein hydrolases from 1457ΔlytSR, contrasted click here to a reduction of 84% or

54% with extracellular murein hydrolases from the parent strain, indicating that disruption of lytSR resulted in decreased activities of extracellular murein hydrolases (Student’s t test, P < 0.05) which probably could not be detected by zymographic analysis. Expression of lytSR in trans restored extracellular murein hydrolase activity to nearly wild-type levels (Figure 6). Figure 6 Quantitative murein

hydrolase assays of S. epidermidis 1457 ΔlytSR. Aliquots (100 μg) of the extracellular proteins concentrated by ultrafiltration Anidulafungin (LY303366) from the supernant were added to a 1-mg/ml suspension of M. luteus (A) and S. epidermidis (B) cells separately, and the turbidity at 600 nm was monitored for 4 h. Cell wall hydrolysis was determined by measurement of turbidity every 30 min. Data are means ± SD of 3 independent experiments. Impact of lytSR knockout on S. epidermidis biofilm formation As biofilm formation is the major determinant of S.epidermidis pathogenicity, the impact of lytSR deletion on biofilm formation was further investigated. Semi-quantitative assay of S.epidermidis biofilm formation in polystyrene microtitre plates was performed and S.epidermidis ATCC12228 was used as a biofilm negative control. It was observed that 1457ΔlytSR produced slightly more biofilm than the wild-type counterpart (Student’s t test, P < 0.05). When lytSR was complemented in the mutant, biofilm formation was reduced to the same levels as that observed in the parent strain (Figure 7). Figure 7 Effect of lytSR gene knocking out on S. epidermidis biofilm formation. The biofilm formation of S. epidermidis ΔlytSR and its parent strain was detected by semi-quantitative microtiter plate assay. Briefly, the overnight bacterial were diluted by 1:200 and cultured in 96-well plate (200 μl/well) at 37 °C for 24 h.

Since strain O104:H4 differs genotypically p38 MAP Kinase pathway and phenotypically from classical STEC, we compared its responses to antibiotics with that of the common STEC strain O157:H7. Results Susceptibility of the growth of STEC strains to select antibiotics in vitro This study characterizes the response to antibiotic treatment of two isolates, P5711 and P5765, of STEC serotype O104:H4 of the German outbreak in 2011 in comparison to the most common STEC reference strain serotype O157:H7, from the National Reference Centre for Salmonella and other bacterial

pathogens causing enteritis, Robert-Koch-Institute, and to the shigatoxin-negative E. coli, ATCC 25922. The minimal inhibitory concentrations (MIC) for the two isolates of O104:H4,

P5711 and P5765, of the antibiotics ciprofloxacin, meropenem, fosfomycin, gentamicin, rifampicin, and chloramphenicol were inconspicuous when compared to the common STEC strain O157:H7 or the STX-negative strain E. coli ATCC 25922 (Table 1). Table 1 Minimal inhibitory concentrations of select antibiotics for two isolates of STEC strain H104:H4, STEC O157:H7, and E. coli ATCC 25922   E. coli strain   O104:H4 O157:H7 ATCC25922   Isolate       P5711 P5765     Antibiotic MIC [mg/l]1 Ciprofloxacin 0.125 0.125 0.064 0.032 Chloramphenicol Seliciclib mw 4.0 4.0 8.0 6.0 Meropenem 0.047 0.047 0.032 0.032 Gentamicin 2.0 2.0 4.0 6.0 Rifampicin Tangeritin 32.0 32.0 16.0 12.0 Fosfomycin 0.25 0.25 0.094 0.19 1 Minimal inhibitory concentrations (MIC) were determined as described in Methods. Values depict the respective

minimal concentration of a given antibiotic that inhibited the visible growth (E-test, BioMerieux). Transcription of the STX2 gene in STEC strains in response to treatment with antibiotics Treatment of STEC with specific antibiotics may rapidly induce a SOS-response starting the lytic cycle of the bacteriophages associated with the transcription of genes coding for shiga toxins (reviewed in [7]). This may result in enhanced production and release of shiga toxins. This apprehended adverse reaction led to the recommendation to refrain from antibiotic treatment during the recent epidemic with STEC O104:H4 in Germany. Subinhibitory concentrations of antibiotics assumed to be present during the early phase of treatment, often lead to the induction of shiga toxin production [3, 4]. Therefore, the mRNA coding for shiga toxin 2 was quantified at 2 h after treatment of fluid phase cultures of STEC O157:H7 and O104:H4 with graded concentrations of antibiotics. Ciprofloxacin at 0.25x MIC and 1x MIC induced STX2-transcripts about 125- and 30-fold, respectively, in the control STEC O157:H7 (Figure 1A). In sharp contrast, O104:H4 responded to 1x MIC of ciprofloxacin only by an about 3- to 4-fold increase in STX2-transcripts.

J Colloid Interface Sci 78:2l2–2l6CrossRef Hirsch RE, Zukin RS, Nagel RL (1980b) Intrinsic fluorescence emission of intact oxy hemoglobins. Biochem Biophys Res Commun 93:432–439CrossRefPubMed Jursinic P, Govindjee (1979) Photosynthesis and fast changes in light emission by green plants. Photochem Photobiol

Rev 4:125–205 Malmberg JH (1957) Aloxistatin cell line Millimicrosecond duration light source. Rev Sci Instr 28:1027–1030CrossRef Papageorgiou GC, Govindjee (eds) (2004) Chlorophyll a fluorecence: a signature of photosynthesis. Springer, Dordrecht (reprinted in 2010 in softcover) Papageorgiou GC, Alygizaki-Zorba A, Loukas S, Brody SS (1996) Photodynamic effect of hypericin on photosynthetic MLN0128 mouse electron transport and fluorescence of Anacystis nidulans (Synechococcus 6301). Photosynth Res 48:221–226CrossRef Porter G, Tredwell CJ, Searle GFW, Barber J (1978) Picosecond time-resolved energy transfer in Porphyridium cruentum. Biochim Biophys Acta 501:232–245CrossRefPubMed Rabinowitch E, Brody SS (1958) Transferts d’energie et photosynthése. J Chim Phys 55:925–933 Rabinowitch E, Govindjee (1960)

Two forms of chlorophyll a in vivo with distinct photochemical functions. Science 132:355–356CrossRefPubMed Rich M, Brody SS (1981) A quantitative comparison of chlorophyll bilayers formed with and without solvent. Photochem Photobiol 33:271–274CrossRef Rich M, Brody SS (1982) Role of various carotenoids in mediating electron transfer sensitized by chlorophyll and pheophytin. FEBS Lett 143:45–48CrossRef Rich M, DeStrulle R, Ferrara G, Brody SS (1992) Dihydroxy-carotenoids inhibit phtotoxicity in Paramecium caudatum. Photochem Photobio 26:413–418 Warden JT, Csatorday K (1987) On the mechanism of linolenic acid inhibition in Photosystem II. Biochim Biophys Acta 890:215–223CrossRefPubMed”
“Introduction Due to their fast growth, homogeneity as cell populations

and easy handling, microalgae attracted plant biologists as laboratory organisms for the study of the metabolism and physiology Farnesyltransferase of photosynthetic cells. This led, for example, to the extensive use of the green alga Chlamydomonas reinhardtii for studying photosynthesis, to such a degree that this alga was nicknamed the green yeast (e.g. Goodenough 1992). Reinforcing the dominant position of Chlamydomonas, the availability of its nuclear genome sequence (Merchant et al. 2007) made also possible the identification of a minimal set of proteins (designated the GreenCut) that were likely involved specifically in chloroplast function within the green lineage. Recent advances in approaching the functions of these proteins are highlighted in this special issue (Grossman et al. 2010).

Furthermore, the MMP2 aptamer-conjugated fluorescent nanoprobe allowed the visualization of atherosclerotic plaques in ApoE knockout mice. These results indicate that the developed MMP2 aptamer provides a suitable basis for the development of diagnostic tools. Acknowledgements This work was supported by the Medical Research Center Program (NRF-2010-0005930) and a grant from the National R&D Program for Cancer Control, Ministry

for Health, Welfare and Family Affairs, Republic of Korea (0920050) and Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry Enzalutamide of Education, Science and Technology (2012R1A1A3010521). Dr. Han ME was financially supported by the 2011 Post-Doc Development Program of Pusan National

University. References 1. Iyer RP, Patterson NL, Fields GB, Lindsey ML: The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol 2012, 303:H919-H930. 2. Hadler-Olsen E, Winberg JO, Uhlin-Hansen L: Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 2013, 34:2041–2051.CrossRef Sotrastaurin solubility dmso 3. Woessner JF Jr: Catabolism of collagen and non-collagen protein in the rat uterus during post-partum involution. Biochem J 1962, 83:304–314. 4. Cybulsky MI, Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Sci (New York, NY) 1991, 251:788–791.CrossRef 5. Jones CB, Sane DC, Herrington DM: Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Fluorometholone Acetate Res 2003, 59:812–823.CrossRef 6. Garcia-Touchard A, Henry TD, Sangiorgi G, Spagnoli LG, Mauriello A, Conover C, Schwartz RS: Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 2005, 25:1119–1127.CrossRef 7. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, Uehira M: Experimental metastasis is suppressed in

MMP-9-deficient mice. Clin Exp Metastasis 1999, 17:177–181.CrossRef 8. Shaw SY: Molecular imaging in cardiovascular disease: targets and opportunities. Nat Rev 2009, 6:569–579. 9. Praseetha PK, Thampy AS, Venugopalan P, Chavali MS: Molecular nanobiotechnological approaches for the detection and therapy of prion related diseases. Nano Biomed Eng 2012, 4:50–57. 10. Lee YJ, Kim IS, Park SA, Kim Y, Lee JE, Noh DY, Kim KT, Ryu SH, Suh PG: Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis. Mol Ther 2013, 21:1004–1013.CrossRef 11. Do Hwang W, Ko HY, Lee JH, Kang H, Ryu SH, Song IC, Lee DS, Kim S: A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 2010, 51:98–105.CrossRef 12. Schafers M, Riemann B, Kopka K, Breyholz HJ, Wagner S, Schafers KP, Law MP, Schober O, Levkau B: Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004, 109:2554–2559.CrossRef 13.

J Food Prot 2005,68(5):1083–1088.PubMed 13. Kaysner CA, DePaola A: Vibrio . In Bacteriological Analytical Manual online. Volume Chapter 9. 9th edition. U.S Food and Drug Administration, Rockville, MD; 2001. 14. Bej AK, Patterson DP, Brasher CW, Vickery MC, Jones DD, Kaysner CA: Detection of total and hemolysin-producing Vibrio parahaemolyticus in shellfish using multiplex PCR amplification of tl , tdh and trh . J Microbiol Methods 1999,36(3):215–225.PubMedCrossRef 15. Gooch JA, DePaola A, Kaysner CA, Marshall DL: Evaluation of two direct plating methods using nonradioactive probes for enumeration of Vibrio parahaemolyticus in oysters. Appl Environ Microbiol 2001,67(2):721–724.PubMedCrossRef

16. Lee CY, Pan SF, Chen CH: Sequence of a cloned pR72H fragment and its use for detection of Vibrio parahaemolyticus in shellfish with the PCR. Appl Environ Microbiol 1995,61(4):1311–1317.PubMed DAPT 17. Venkateswaran

K, Dohmoto N, Harayama S: Cloning and nucleotide sequence of the gyrB gene of Vibrio parahaemolyticus and its application in detection of this pathogen in shrimp. Appl Environ Microbiol 1998,64(2):681–687.PubMed 18. Kim YB, Okuda J, Matsumoto C, Takahashi N, Hashimoto S, Nishibuchi M: Identification of Vibrio parahaemolyticus strains at the species level by PCR targeted to the toxR gene. J Clin Microbiol 1999,37(4):1173–1177.PubMed 19. Nordstrom JL, Vickery MC, Blackstone GM, Murray SL, DePaola A: Development of a Caspase inhibitor multiplex real-time PCR assay with an internal amplification control for the detection of total and pathogenic Vibrio parahaemolyticus bacteria in oysters. Appl Environ Microbiol 2007,73(18):5840–5847.PubMedCrossRef 20. Kim JS, Lee GG, Kim J, Kwon JY, Kwon ST: The development of rapid real-time PCR detection system for Vibrio parahaemolyticus

in raw oyster. Lett Appl Microbiol 2008,46(6):649–654.PubMedCrossRef 21. Ward LN, Bej AK: Detection of Vibrio parahaemolyticus in shellfish by use of multiplexed real-time PCR with TaqMan fluorescent probes. Appl Environ Microbiol 2006,72(3):2031–2042.PubMedCrossRef 22. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T: Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000,28(12):E63.PubMedCrossRef 23. Han F, Phospholipase D1 Ge B: Evaluation of a loop-mediated isothermal amplification assay for detecting Vibrio vulnificus in raw oysters. Foodborne Pathog Dis 2008,5(3):311–320.PubMedCrossRef 24. Hara-Kudo Y, Yoshino M, Kojima T, Ikedo M: Loop-mediated isothermal amplification for the rapid detection of Salmonella . FEMS Microbiol Lett 2005,253(1):155–161.PubMedCrossRef 25. Parida M, Posadas G, Inoue S, Hasebe F, Morita K: Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of West Nile virus. J Clin Microbiol 2004,42(1):257–263.PubMedCrossRef 26.

Recently, we have found that the hydrothermal treatment (HTT), which is a heat treatment under relative humidity of 100%, is

effective for controlling the dye aggregation states when it is applied to the well-known MS-C20 binary LB film [16–26]. The as-deposited J-band originally located around 590 nm is reorganized by HTT to form a new phase associated with a further narrowing and a red shift of the peak [16–26]. We have already investigated kinetics of hydrothermally induced reorganization of J-aggregate in the mixed MS-C20 LB system and have pointed out that the UV-visible absorption spectra can be deconvoluted to three components: Band I (centered at 500 to 515 nm), Band II (centered at 545 to 555 nm), and Band III (centered at 590 to 598 nm) [17, 19, 22, 26]. Band I, Quizartinib concentration BAY 73-4506 clinical trial Band II, and Band III are assigned as the blue-shifted dimer, monomer, and red-shifted J-aggregate, respectively. Furthermore, the HTT process consists of following two stages. The first stage is characterized by the decrease in the Band III component

associated with the increase in the Band I component, which is hypothesized as a dissociation process of the original J-aggregate (Band III centered at 590 nm) to the blue-shifted dimer (centered at 500 to 515 nm). The second stage is characterized as the reorganization of Band III (centered at 597 to 599 nm) from Band I (500 to 515 nm). Since the component of Band II (centered 4��8C at 545 to 555 nm) is almost unchanged throughout the whole HTT process, we have described that the growth and decay processes in the second stage are assumed to be a first-order reaction between Band I and Band III components [22, 26]. We have also reported that the HTT process induces a unique superstructure in the MS-C20 binary LB systems [18, 20–25]. Giant round-shaped domains with diameters reaching 100 μm are observed by optical microscopy. In those papers, we have touched

upon the sizes of the round-shaped domains depending on heating temperature (T H) and heating time (t H) and found that the average size of the domains tends to increase superlinearly depending on T H and t H. However, due to insufficient color sensitivity and resolution of the optical microscope used for the observation, the surface structure had not been characterized in detail [18, 20–25]. Since J-aggregate is known to emit intense fluorescence, fluorescence (FL) microscopy is considered to be a powerful tool to characterize the system. In this paper, we report on surface morphology of the MS-C20 binary LB films before and after HTT process combining bright field (BF) microscopy and FL microscopy and discuss the possible mechanisms of the J-aggregate reorganization. Methods Fabrication of the mixed LB films of Merocyanine and arachidic acid The film-forming materials, merocyanine dye (MS in Figure 1) and arachidic acid (C20 in Figure 1), were purchased from Hayashibara Biochemical Lab. Inc. (Okayama, Japan) and Fluka AG (St.